Evidence map›Paper›PMID 20823260›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2010

Selective cell death mediated by small conditional RNAs.

Suvir Venkataraman, Robert M Dirks, Christine T Ueda, Niles A Pierce

RetractedOpen access · greenAbstract readRetracted Publication
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
9.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 88 citations in OpenAlex.

  1. Article
  2. Production of Fatty Acid-derived valuable chemicals in synthetic microbes.Frontiers in bioengineering and biotechnology · 2014
    Review
  3. Article
  4. Article
  5. Self-assembled, aptamer-tethered DNA nanotrains for targeted transport of molecular drugs in cancer theranostics.Proceedings of the National Academy of Sciences of the United States of America · 2013
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. De novo automated design of small RNA circuits for engineering synthetic riboregulation in living cells.Proceedings of the National Academy of Sciences of the United States of America · 2012
    Article
  12. Multiplexed in situ immunofluorescence using dynamic DNA complexes.Angewandte Chemie (International ed. in English) · 2012
    Article
  13. Synthetic in vitro circuits.Current opinion in chemical biology · 2012
    Review
  14. Article
  15. Article
  16. Article
  17. Abstractions for DNA circuit design.Journal of the Royal Society, Interface · 2012
    Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Suvir VenkataramanDepartment of Bioengineering, California Institute of Technology, Pasadena, CA 91125, USA.
Robert M Dirks
Christine T Ueda
Niles A Pierce
California Institute of Technology · USBioengineering Center · RUDivision of Chemistry · US

Funding

Engineering Triggered Nanomechanical TherapeuticsR01CA140759 · NCI · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI PIERCE, NILES A · 2009 to 2013
$1.6M
NCI NIH HHS R01 CA140759
6 · The paper itself

Abstract

Cancer cells are characterized by genetic mutations that deregulate cell proliferation and suppress cell death. To arrest the uncontrolled replication of malignant cells, conventional chemotherapies systemically disrupt cell division, causing diverse and often severe side effects as a result of collateral damage to normal cells. Seeking to address this shortcoming, we pursue therapeutic regulation that is conditional, activating selectively in cancer cells. This functionality is achieved using small conditional RNAs that interact and change conformation to mechanically transduce between detection of a cancer mutation and activation of a therapeutic pathway. Here, we describe small conditional RNAs that undergo hybridization chain reactions (HCR) to induce cell death via an innate immune response if and only if a cognate mRNA cancer marker is detected within a cell. The sequences of the small conditional RNAs can be designed to accept different mRNA markers as inputs to HCR transduction, providing a programmable framework for selective killing of diverse cancer cells. In cultured human cancer cells (glioblastoma, prostate carcinoma, Ewing's sarcoma), HCR transduction mediates cell death with striking efficacy and selectivity, yielding a 20- to 100-fold reduction in population for cells containing a cognate marker, and no measurable reduction otherwise. Our results indicate that programmable mechanical transduction with small conditional RNAs represents a fundamental principle for exploring therapeutic conditional regulation in living cells.

Indexed as

ApoptosisHybridization, GeneticImmunity, InnateBiomarkers, TumorCell SurvivalHumansMechanotransduction, CellularMicroRNAsNeoplasmsTransduction, GeneticTumor Cells, CulturedBiomarkers, TumorMicroRNAs

Identifiers

PMID20823260
PMCPMC2947873
OpenAlexW2075077797

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.